Insulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout November
November 01 2023 - 6:00AM
Business Wire
Highlights Include Pledge to End Diabetes
Stigma, Nasdaq Closing Bell Ceremony, and Educational Events
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the
global leader in tubeless insulin pump technology with its Omnipod®
brand of products, today announced a series of initiatives in
recognition of National Diabetes Awareness Month and World Diabetes
Day.
“Our commitment to people with diabetes extends beyond our
innovative insulin delivery technology,” said Jim Hollingshead,
President and Chief Executive Officer. “World Diabetes Day may be
just one day on the calendar, but for those living with diabetes,
every day requires resilience and strength. By raising awareness
today, we pave the way for a world where care, support, and
understanding are accessible to all who need it.”
World Diabetes Day
World Diabetes Day is recognized globally on Tuesday, November
14, and the Insulet team will appear at the Nasdaq Stock Market for
the ninth consecutive year by ringing the closing bell at 4:00 p.m.
ET. Mr. Hollingshead will be joined by a group of global Insulet
employees and customers and will speak about the importance of
raising diabetes awareness and Insulet’s mission. The Nasdaq Stock
Market closing bell ceremony will be aired live on the Nasdaq
website and broadcast on CNBC and MSNBC TV.
Earlier that day, Insulet employees will join the American
Association of Nurse Practitioners (AANP) at NBC’s TODAY Show, to
recognize Nurse Practitioner Week and the important role nurse
practitioners play in diabetes management. The intersection of
World Diabetes Day and Nurse Practitioner Week provides the perfect
opportunity to highlight Insulet employees who are also
professionally trained and certified as nurse practitioners.
Diabetes Awareness Month Activities
- Pledge to End Diabetes Stigma – Insulet has endorsed an
international campaign to eliminate diabetes stigma and
discrimination. The diaTribe Foundation and the Australian Centre
for Behavioural Research in Diabetes are convening the global
diabetes community to encourage non-profits, industry partners,
healthcare professionals, people with diabetes, and allies and the
general public to endorse the pledge.
- Education for Clinicians – Members of the Association of
Diabetes Care and Education Specialists (ADCES) based in New
England are invited to Insulet’s Acton, Massachusetts global
headquarters on November 2. The event, hosted by the ADCES
Massachusetts Coordinating Body, is designed to empower and support
clinicians in their care of people with diabetes.
- #JustMyType Social Media Campaign – Insulet is encouraging the
global diabetes community to create awareness and increase
representation of people with diabetes through its #JustMyType
campaign. The Company will feature content on its social media
channels and will encourage others to participate on their own
social channels.
- Omnipod Ambassador Event – On November 11, Insulet is
co-hosting a special event for Podders® and Dexcom Warriors from
Germany and the UK, bringing content creators together to
collaborate and create diabetes-related content to educate the
public, broaden awareness, and inspire people with diabetes.
Orli Adamski is a 16-year-old from New York who has been
advocating for people with diabetes since she was diagnosed at age
seven. Ms. Adamski will join the Insulet team at the Nasdaq closing
bell ceremony, representing the Podder community, just as she did
last summer as a delegate to JDRF’s 2023 Children’s Congress.
“There are no breaks with type 1 diabetes,” said Ms. Adamski.
“It impacts every single moment of my life, and so many other
lives. It’s important to create awareness of the challenges that
people with diabetes face, including gaining access to technology
like Omnipod 5.”
In order to better serve Insulet’s customers, the Company is
also planning various employee events and activities to increase
awareness of diabetes.
To learn more about diabetes or to access helpful resources for
living with diabetes, visit the American Diabetes Association,
JDRF, and the International Diabetes Federation.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in
Massachusetts, is an innovative medical device company dedicated to
simplifying life for people with diabetes and other conditions
through its Omnipod product platform. The Omnipod Insulin
Management System provides a unique alternative to traditional
insulin delivery methods. With its simple, wearable design, the
disposable Pod provides up to three days of non-stop insulin
delivery, without the need to see or handle a needle. Insulet’s
latest innovation, the Omnipod 5 Automated Insulin Delivery System,
is a tubeless automated insulin delivery system, integrated with a
continuous glucose monitor to manage blood sugar with no multiple
daily injections and zero fingersticks. Insulet also leverages the
unique design of its Pod by tailoring its Omnipod technology
platform for the delivery of non-insulin subcutaneous drugs across
other therapeutic areas. For more information, please visit:
insulet.com and omnipod.com.
©2023 Insulet Corporation. Omnipod is a registered trademark of
Insulet Corporation in the United States of America and other
various jurisdictions. All rights reserved. All other trademarks
are the property of their respective owners. The use of third-party
trademarks does not constitute an endorsement or imply a
relationship or other affiliation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231101906729/en/
Investor Relations: Deborah R. Gordon Vice President,
Investor Relations (978) 600-7717 dgordon@insulet.com
Media: Angela Geryak Wiczek Senior Director, Corporate
Communications (978) 932-0611 awiczek@insulet.com
Insulet (NASDAQ:PODD)
Historical Stock Chart
From Apr 2024 to May 2024
Insulet (NASDAQ:PODD)
Historical Stock Chart
From May 2023 to May 2024